India has the highest prevalence of diabetes globally, with an estimated 77 million people living with the condition and an expected 134 million cases by 2045
The U.S. FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
Pirfenidone Capsules had estimated annual sales of USD 95 million in the US
Propranolol LA is a generic equivalent of Inderal LA
This product will be manufactured at Lupin's Pithampur facility in India
Bromfenac Ophthalmic Solution 0.09% (RLD Bromday) had estimated annual sales of USD 11 million in the U.S. (IQVIA MAT June 2023).
This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes
Jeet will be a trusted partner in cardiovascular care
Subscribe To Our Newsletter & Stay Updated
